Management of Outpatients With Diabetes at High Risk of Hypoglycemia.
Management of Outpatients With Diabetes at High Risk of Hypoglycemia. JAMA. 2024 04 02; 331(13):1145-1146.
PMID: 38483370
Racial Discrimination, Inflammation, Sleep, and Metabolic Syndrome From Adolescence to Young Adulthood.
Racial Discrimination, Inflammation, Sleep, and Metabolic Syndrome From Adolescence to Young Adulthood. JAMA Netw Open. 2024 04 01; 7(4):e245258.
PMID: 38635277
Stress and human health in diabetes: A report from the 19th Chicago Biomedical Consortium symposium.
Stress and human health in diabetes: A report from the 19th Chicago Biomedical Consortium symposium. J Clin Transl Sci. 2023; 7(1):e263.
PMID: 38229904
Reducing Inpatient Hypoglycemic Events: A Focus on Mealtime Insulin.
Reducing Inpatient Hypoglycemic Events: A Focus on Mealtime Insulin. Clin Diabetes. 2022; 40(3):366-369.
PMID: 35983427
Longer-term Benefits and Risks of Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: a Systematic Review and Meta-analysis.
Longer-term Benefits and Risks of Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: a Systematic Review and Meta-analysis. J Gen Intern Med. 2022 02; 37(2):439-448.
PMID: 34850334
The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis.
The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis. J Gen Intern Med. 2022 02; 37(2):415-438.
PMID: 34508290
Broadening Access to Continuous Glucose Monitoring for Patients With Type 2 Diabetes.
Broadening Access to Continuous Glucose Monitoring for Patients With Type 2 Diabetes. JAMA. 2021 06 08; 325(22):2255-2257.
PMID: 34077505
Updates in Gestational Diabetes Prevalence, Treatment, and Health Policy.
Updates in Gestational Diabetes Prevalence, Treatment, and Health Policy. Curr Diab Rep. 2019 05 09; 19(6):33.
PMID: 31073850
Primary Care Endocrinology in the Adult Woman.
Primary Care Endocrinology in the Adult Woman. Obstet Gynecol Clin North Am. 2016 Jun; 43(2):325-46.
PMID: 27212095
Dietary exposure to the endocrine disruptor tolylfluanid promotes global metabolic dysfunction in male mice.
Dietary exposure to the endocrine disruptor tolylfluanid promotes global metabolic dysfunction in male mice. Endocrinology. 2015 Mar; 156(3):896-910.
PMID: 25535829